Health

Current Picks

Kenyan Insurance Denies HIV PrEP Reauthorization While Private Pharmacies Sell Single Pills

By Elena Vargas / Jul 18, 2026

Kenya's NHIF stops reauthorizing HIV PrEP, forcing patients to buy single pills at private pharmacies. A deep dive into the broken prior authorization system and its impact on HIV prevention.

Kenyan Public Insurance Covers One Antidepressant While Private Plans Offer Four Generations

By Raphael Andriamanjato / Jul 20, 2026

Kenya's NHIF covers only fluoxetine, while private insurers list four generations of antidepressants. The gap in access drives inequity in depression treatment.

Private Insurers Cover Drug-Cost Caps While State Medicaid Plans Deny Same Therapies

By Min Park / Jul 18, 2026

Private insurers cap drug copays at $150 while Medicaid patients face $800+ for the same medication. This article examines the disparities in formulary design, prior authorization, and policy levers to close the gap.

Kenyan Maternity Cover Stops at Vaginal Birth While C-Section Recovery Goes Uninsured

By Elena Vargas / Jul 18, 2026

Kenya's Linda Mama program fully covers vaginal delivery but leaves C-section recovery uninsured, creating a policy gap that drives maternal mortality and widens health inequity.

Mothers Hail Community Health Workers as Delhi Public Hospitals Deny Maternity Beds

By Esther Okello / Jul 18, 2026

Delhi's public hospitals routinely deny maternity beds, forcing women to rely on community health workers. A look at the billing chasm, drug shortages, and system failures.

Zambian Antipsychotic Doses Double by Instinct as Therapeutic Drug Monitors Sit Idle

By Esther Okello / Jul 18, 2026

In Zambia, psychiatrists double antipsychotic doses by instinct because expensive drug-monitoring machines sit unused. A low-cost dried blood spot pilot in Malawi offers a way forward.

UK Oncology Nurses Spot Trial-Eligible Mutations That Genomic Panels Routinely Miss

By Min Park / Jul 18, 2026

Routine genomic panels miss 5–10% of actionable mutations. UK oncology nurses at district hospitals spot these gaps, enabling trial access that would otherwise be lost.

UK Colorectal Surgeons Skip FIT Triage While Patients Wait Six Months for Colonoscopy

By Elena Vargas / Jul 18, 2026

Despite NHS guidelines recommending the faecal immunochemical test (FIT) before colonoscopy, many UK surgeons skip it, contributing to six-month waits and later-stage diagnoses.

Rwanda Stockpiles HPV Vaccine for Five-Year-Olds While Adult Women Self-Screen at Home

By Raphael Andriamanjato / Jul 18, 2026

Rwanda's HPV vaccine stockpile for five-year-olds and home self-screening for adult women spark debate among experts on cost-effectiveness and resource allocation in cervical cancer prevention.

UK Spirometry Rates Drop as GPs Diagnose Asthma by Symptom History Alone

By Raphael Andriamanjato / Jul 18, 2026

Spirometry rates in UK primary care have fallen by roughly 15% since 2020. Over 60% of new asthma diagnoses now rely on symptom history alone, raising concerns about misdiagnosis and inappropriate treatment.

Dutch Mammography False Positives Alarm Women While Radiologists Call Them Acceptable Risk

By Elena Vargas / Jul 18, 2026

In the Netherlands, roughly 1 in 10 screening mammograms leads to a recall, most proving benign. Women describe lasting anxiety while radiologists defend the rate as a necessary trade-off.

Zambian Stroke Patients Miss Thrombolysis Window as CT Scanners Sit in Customs

By Raphael Andriamanjato / Jul 18, 2026

Zambia's stroke patients miss the 4.5-hour thrombolysis window as CT scanners remain stuck in customs for months. Without imaging, clinicians cannot distinguish hemorrhagic from ischemic stroke, delaying life-saving treatment.

Hypertension Algorithm Recommends One Drug While Patient’s Kidney Reads Another

By Esther Okello / Jul 23, 2026

Standard hypertension guidelines recommend thiazide diuretics first-line, but in chronic kidney disease, altered kidney physiology often makes them ineffective. This mismatch leaves millions with uncontrolled blood pressure.

Hypertensive Farm Workers in Rural Kenya Need Daily Meds While Clinics Stock Only Monthly Supplies

By Raphael Andriamanjato / Jul 18, 2026

In rural Kisumu, hypertensive farm workers struggle with monthly refills that require hours of travel. Experts debate whether multi-month dispensing could save lives.

UK Antidepressant Prescriptions Doubled While Relapse Prevention Trials Remain Underfunded

By Min Park / Jul 18, 2026

UK antidepressant prescriptions have doubled in a decade, yet relapse prevention trials remain scarce. This article explores the evidence gap in maintenance therapy and its impact on long-term care.

India Public Psychiatric Hospitals Admit Severe Cases While Private Beds Treat Insured Depression

By Min Park / Jul 18, 2026

India's public psychiatric hospitals overflow with severe cases, while private beds for depression sit half-empty. Insurance exclusions and stigma widen the treatment gap.

Nigerian Rural Maternity Centres Pay Midwife Salaries While Urban Hospitals Recruit Doctors

By Raphael Andriamanjato / Jul 18, 2026

Urban hospitals in Lagos pay doctors up to ₦500,000 monthly, while rural maternity centres in Zamfara pay midwives ₦80,000–120,000. This salary gap fuels a recruitment crisis and drives maternal mortality.

Zambia Public Depression Care Caps at Six Sessions While Private Therapy Runs Unlimited

By Elena Vargas / Jul 18, 2026

In Zambia, public mental health care limits depression treatment to six sessions, while private clinics offer unlimited therapy. This gap widens inequity in a country where few receive any care.

Ruptured Tuberculosis Bubbles Kill Lima Miners as Clinics Lack GeneXpert Cartridges

By Esther Okello / Jul 18, 2026

In Peru's high Andes, silver miners die of drug-resistant TB as GeneXpert machines sit idle for lack of $8 cartridges. A broken supply chain fuels resistance and spreads disease.

Philippine Public Clinics Stock Ceftriaxone While Resistant Typhoid Circulates in Manila Slums

By Min Park / Jul 18, 2026

Public clinics in Manila's slums stock ceftriaxone—a third-line antibiotic—for typhoid, while resistant strains spread and vaccination coverage lags. Payer rules and infrastructure gaps perpetuate a dangerous cycle.